Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Moderna Says Coronavirus Vaccine Works Well For Children Six To 12

    The Wall Street Journal (10/25, Loftus, Subscription Publication) reports Moderna said trial data show its COVID-19 vaccine induced strong immune responses in children from six to 11 years of age. The New York Times (10/25, Mandavilli) says the children i...
    Full Article
  • NIH To Invest $70M To Increase Availability Of Rapid At-Home COVID-19 Tests

    The Washington Post (10/25, Abutaleb) reports, “The Biden administration announced additional steps on Monday to increase the availability of rapid at-home coronavirus tests and bring down their cost” through a $70 million National Institutes of Health in...
    Full Article
  • Hospital Surfaces Covered With Foil Containing Silver-Based Agent May Decrease Spread Of Clinical Pathogens, Study Says

    According to Infectious Disease Advisor (10/25, Nye), “In regard to high-touch surfaces in hospitals, covering the surface with a foil containing a silver-based agent may decrease the risk for transmission of important clinical pathogens,” researchers rep...
    Full Article
  • China Sees Rise In Human Bird Flu Cases, Raising Concerns Over Variants

    Reuters (10/26, Patton) reports, “A jump in the number of people in China infected with bird flu this year is raising concern among experts, who say a previously circulating strain appears to have changed and may be more infectious to people.” The country...
    Full Article
  • China Begins Vaccinating Children As Young As Three Against SARS-CoV-2

    The AP (10/25, Wu) reports that “children as young as 3 will start receiving COVID-19 vaccines in China, where 76% of the population has been fully vaccinated and authorities are maintaining a zero-tolerance policy toward outbreaks.” According to the AP,...
    Full Article
  • Influenza B/Yamagata Strain Not Found In Flu Case Tracking Since March 2020, Researchers Find

    HealthDay (10/25, Thompson) reports, “Influenza B/Yamagata is one of four strains regularly included in annual flu shots, but in the midst of COVID-19 lockdowns that strain appears to have fallen completely off the radar, an Australian research team recen...
    Full Article
  • UK Reports Increasing Rates Of “Flesh-Eating” STI

    USA Today (10/25, Gleeson) reports, “A flesh-eating sexually transmitted infection that causes ‘beefy red’ ulcers is becoming more prevalent in the United Kingdom, a new report out Friday revealed.” While still rare, the infection, donovanosis, “has been...
    Full Article
  • Patients With HIV/AIDS Press Supreme Court On Mail-Order Pharmacy Policy

    Bloomberg Law (10/25, Pazanowski, Subscription Publication) reports, “Federal disability bias laws prohibit a mail-order pharmacy policy that has an unintended discriminatory effect on HIV/AIDS patients and other people with disabilities, the patients tol...
    Full Article
  • Some CDC, FDA Expert Panelists Hesitant To Say COVID-19 Boosters Are Widely Necessary

    The New York Times (10/25, Mandavilli) reports, “Following a series of endorsements over the last month by scientific panels advising federal agencies, tens of millions of Americans are now eligible for booster shots of coronavirus vaccines.” However, FDA...
    Full Article
  • Benefits Of Pfizer/BioNTech COVID-19 Vaccine Outweigh Risks In Children Ages 5 To 11, FDA Review Finds

    The Washington Post (10/22, A1, Johnson, McGinley) reported that the Pfizer-BioNTech COVID-19 “vaccine appears poised to become available to children 5 to 11 years old within weeks, after” an FDA “review found the benefits of the shot outweigh the risks i...
    Full Article
  • Americans Seek Out COVID-19 Boosters After CDC Approves J&J, Moderna Shots

    The Washington Post (10/23, Shepherd, Sun) reported Americans “rushed to get additional shots on Friday, just hours after federal officials cleared both the Johnson & Johnson and Moderna boosters.” According to the Post, “Many consumers were buoyed by the...
    Full Article
  • Study Finds No Significant Change In Outcomes Among Patients Hospitalized With COVID-19 During Delta Variant Surge

    The New York Times (10/22, Mueller) reported a CDC study “examined roughly 7,600 Covid hospitalizations, comparing July and August --” when the Delta coronavirus variant “dominated – to earlier months this year, and found no significant change in hospital...
    Full Article
  • Long-Acting Injectable Cabotegravir Plus Rilpivirine Safe, Effective, Well-Tolerated At 124 Weeks In FLAIR Trial

    Healio (10/22, Stulpin) reported trial data indicate “long-acting injectable cabotegravir plus rilpivirine effectively maintained viral suppression of HIV among adults with or without a 1-month oral lead-in phase.” According to the results of the “ongoing...
    Full Article
  • Review Examines Effect Of Sofosbuvir-Based Direct-Acting Antivirals On Lower-Density Lipoprotein Levels In Patients With HCV

    Infectious Disease Advisor (10/22, Gupta) reported, “Although the initial 4 weeks of treatment with a sofosbuvir (SOF)-based direct-acting antiviral (DAA) was associated with a significant increase in lower‑density lipoprotein (LDL) concentrations among p...
    Full Article
  • Research Studies Effect Of Routine Lubricant Use On Vaginal Cytokine, Microbiota Profiles Among Women Who Engage In Condomless Vaginal Intercourse

    Infectious Disease Advisor (10/22, Gupta) reported research indicates that while “there were few differences overall in vaginal cytokine and microbiota profiles before and after condomless vaginal intercourse between women who use lubricants vs those who...
    Full Article
  • Walmart Recalling Aromatherapy Room Spray Over Burkholderia Pseudomallei Bacteria Risk

    USA Today (10/22, Tyko) reported, “Walmart is recalling a limited number of bottles of aromatherapy room spray because they may contain ‘a rare and dangerous bacteria and risk of serious injury and death.’” The recall “is for 3,900 bottles of ‘Better Home...
    Full Article
  • CDC Not Planning To Update Mask Guidelines As COVID-19 Transmission Rates Remain High In US

    Newsweek (10/22, Fung) reported the CDC “is not planning to change their guidelines on mask wearing anytime soon as transmission rates across the country remain high or substantial in over 90 percent of counties.” The agency “recommends that vaccinated pe...
    Full Article
  • Namibia To Suspend Use Of Russia’s Sputnik V COVID-19 Vaccine

    Reuters (10/24, Nyaungwa, Devitt) reports, “Namibia will suspend its rollout of Russia’s Sputnik V COVID-19 vaccine, its health ministry said on Saturday, days after the drugs regulator in neighbouring South Africa flagged concerns about its safety for pe...
    Full Article
  • CDC Endorses Advisory Panel’s Recommendation For J&J, Moderna, And Mix-And-Match COVID-19 Boosters

    The Washington Post (10/21, A1, Sun, Shepherd) reports, “Tens of millions of Americans can sign up to get Moderna and Johnson & Johnson boosters beginning Friday after” CDC Director Dr. Rochelle Walensky “endorsed recommendations from expert advisers that...
    Full Article
  • Q-HCL Increases aBL Efficacy In Patients With Cutaneous Mold Infections, Results Show

    Infectious Disease Advisor (10/21, Mermelstein) reports, “Quinine hydrochloride (Q-HCL) was found to significantly increase the efficacy of antimicrobial blue light (aBL) therapy in patients with cutaneous mold infections,” data published in the Journal o...
    Full Article
  • «
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id